| Apr 7 |
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
|
| Mar 29 |
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
|
| Mar 29 |
63 Biggest Movers From Friday
|
| Mar 26 |
Helius Medical surges on FDA authorization for neuromodulation stimulator (updated)
|
| Mar 17 |
Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd
|
| Mar 17 |
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors
|
| Mar 11 |
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call Transcript
|
| Mar 10 |
Helius Medical Technologies EPS misses by $1.69, beats on revenue
|
| Mar 10 |
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
|
| Mar 10 |
Earnings Scheduled For March 10, 2021
|
| Feb 2 |
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021
|
| Feb 1 |
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
|
| Jan 28 |
Helius Medical drops 16% after $9.6M capital raise
|
| Jan 28 |
IIROC Trade Resumption - HSM
|
| Jan 28 |
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market
|
| Jan 28 |
IIROC Trading Halt - HSM
|
| Jan 20 |
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices
|
| Jan 19 |
Helius Medical regains Nasdaq listing compliance
|
| Jan 19 |
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards
|
| Jan 15 |
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference
|
| Jan 13 |
Sidoti Virtual Investor Conference
|
| Jan 11 |
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis
|
| Jan 5 |
Helius Medical Technologies, Inc. Comments on Unusual Market Activity
|
| Jan 4 |
11 Health Care Stocks Moving In Monday's Intraday Session
|
| Jan 4 |
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January
|
